Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 20, 2015 13:30 ET | Source: NGM Biopharmaceuticals, Inc.

NGM Biopharmaceuticals to Present New Data on NGM282 at the European Association for the Study of the Liver International Liver Congress(TM) 2015

SOUTH SAN FRANCISCO, Calif., April 20, 2015 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc., a privately held biotechnology company that seeks to translate powerful biology into transformative...
March 24, 2015 09:00 ET | Source: NGM Biopharmaceuticals, Inc.

NGM Biopharmaceuticals Announces Positive Phase 2 Clinical Data in Primary Biliary Cirrhosis Patients for NGM282, a First-in-Class Investigational Medicine

Data demonstrate statistically significant, dose-dependent and clinically meaningful reductions in disease activity Results support NGM282 as a potential treatment for a variety of orphan...
March 02, 2015 09:00 ET | Source: NGM Biopharmaceuticals, Inc.

NGM Biopharmaceuticals Announces Expansion of Management Team

SOUTH SAN FRANCISCO, Calif., March 2, 2015 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc., a privately-held biopharmaceutical company, today announced that Jeff Jonker has been named President and...